FemHealth Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
GT Medical TechnologiesMay 2026 · $100M
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)James Leech(Executive Officer)Matthew E. Likens(Executive Officer, Director)
BoardGeoff Pardo(Director)inPrattipati Laxminarain(Director)
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health CapitalGilde HealthcareMedical Technology Venture PartnersMedTech Venture Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.